Who owns AADI BIOSCIENCE INC COM?
- Ticker: WHWK
- CUSIP Number: 00032q104
Tip: Access positions for across all investors
Analyze quarterly positions in Aadi Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aadi Bioscience stock
Who bought or sold AADI BIOSCIENCE INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| QVT Financial | 4.6M | $16M | 0% | Mar 2026 |
|
| OrbiMed Advisors | 4.2M | $14M | 0% | Mar 2026 |
|
| Suvretta Capital Management | 3.7M | $13M | 0% | Mar 2026 |
|
| Longwood Capital Partners | 3.4M | $12M | 0% | Mar 2026 |
|
| venBio Select Advisor | 2.8M | $6.9M | 0% | Dec 2025 |
|
| KVP Capital Advisors | 2.2M | $7.5M | 0% | Mar 2026 |
|
| Siren | 2.1M | $5.0M | 0% | Dec 2025 |
|
| Yu Fan | 2.1M | $7.1M | 0% | Mar 2026 |
|
| Vanguard Group | 1.6M | $3.8M | 18% | Dec 2025 |
|
| Vanguard Capital Management | 1.3M | $4.5M | 100% | Mar 2026 |
|
| Acorn Capital Advisors | 1.1M | $2.8M | 0% | Dec 2025 |
|
| Stempoint Capital | 939k | $3.2M | -36% | Mar 2026 |
|
| Ally Bridge Group | 818k | $2.8M | 0% | Mar 2026 |
|
| Balyasny Asset Management | 550k | $1.9M | 100% | Mar 2026 |
|
| Geode Capital Management | 458k | $1.6M | 8% | Mar 2026 |
|
| Renaissance Technologies | 441k | $1.1M | -4% | Dec 2025 |
|
| BlackRock | 351k | $1.2M | 18% | Mar 2026 |
|
| Millennium Management | 310k | $1.1M | 100% | Mar 2026 |
|
| Woodline Partners | 282k | $971k | 100% | Mar 2026 |
|
| Two Sigma Investments | 274k | $944k | -12% | Mar 2026 |
|
| Eversept Partners | 260k | $630k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 215k | $521k | 0% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 215k | $741k | 100% | Mar 2026 |
|
| Jane Street | 171k | $590k | 145% | Mar 2026 |
|
| State Street Corporation | 146k | $352k | 112% | Dec 2025 |
|
| ADAR1 Capital Management | 129k | $443k | 66% | Mar 2026 |
|
| Susquehanna International | 110k | $266k | 100% | Dec 2025 |
|
| Northern Trust | 104k | $250k | 43% | Dec 2025 |
|
| Citadel Advisors | 92k | $317k | -7% | Mar 2026 |
|
| Qube Research & Technologies | 72k | $175k | 100% | Dec 2025 |
|
| Acadian Asset Management | 70k | $239k | 185% | Mar 2026 |
|
| Marshall Wace | 68k | $165k | 100% | Dec 2025 |
|
| Hudson Bay Capital Management | 58k | $199k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 57k | $196k | 100% | Mar 2026 |
|
| Seven Fleet Capital Management | 54k | $187k | 100% | Mar 2026 |
|
| Bank of America Corporation | 53k | $182k | 100% | Mar 2026 |
|
| Hrt Financial | 35k | $120k | 100% | Mar 2026 |
|
| Bailard | 31k | $108k | 100% | Mar 2026 |
|
| Dimensional Fund Advisors | 30k | $104k | 5% | Mar 2026 |
|
| Point72 Asset Management | 28k | $97k | 100% | Mar 2026 |
|
| Catalyst Funds Management Pty | 27k | $93k | 100% | Mar 2026 |
|
| Occudo Quantitative Strategies | 22k | $89k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 20k | $70k | 100% | Mar 2026 |
|
| Springbok Capital Management | 19k | $46k | 100% | Dec 2025 |
|
| XTX Topco | 16k | $38k | -21% | Dec 2025 |
|
| Brevan Howard Capital Management | 13k | $43k | 100% | Mar 2026 |
|
| OMERS Administration Corporation | 12k | $40k | 100% | Mar 2026 |
|
| Quadrature Capital | 11k | $28k | 100% | Dec 2025 |
|
| UBS Group | 11k | $40k | -62% | Mar 2026 |
|
| Morgan Stanley | 8.3k | $29k | 24% | Mar 2026 |
|
| Citigroup | 6.2k | $21k | 100% | Mar 2026 |
|
| Ames National Corp | 4.6k | $1.3M | 100% | Mar 2026 |
|
| Us Bancorp | 3.3k | $8.1k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 3.1k | $7.4k | 0% | Dec 2025 |
|
| Bartlett & Co. Wealth Management | 1.3k | $5.5k | 0% | Mar 2026 |
|
| Russell Investments | 386.00 | $1.3k | 0% | Mar 2026 |
|
| TD Waterhouse Canada | 232.00 | $813.995200 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 202.00 | $697.001000 | 26% | Mar 2026 |
|
| Royal Bank of Canada | 177.00 | $999.996900 | 100% | Mar 2026 |
|
| CWM | 25.00 | $0 | 0% | Dec 2025 |
|
| SBI Securities | 23.00 | $79.000400 | 21% | Mar 2026 |
|
| Parallel Advisors | 8.00 | $28.000000 | 0% | Mar 2026 |
|
Who sold out of Aadi Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 42k | $103k |
| Stonepine Capital Management | Sep 2025 | 35k | $67k |
| ABG Innovation Capital Partners III GP | Dec 2025 | 27k | $65k |
| Tower Research Capital | Sep 2025 | 797.00 | $1.5k |
| Jpmorgan Chase & Co | Sep 2025 | 421.00 | $799.984200 |
| Group One Trading | Dec 2025 | 100.00 | $242.000000 |
| Simplex Trading | Sep 2025 | 35.00 | $0 |